Related Experiment Video
Updated: Oct 22, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
Anna Szpakowicz1, Malgorzata Szpakowicz2, Magda Lapinska2
1Department of Cardiology, Medical University of Bialystok, ul.Jana Kilinskiego 1, 15-089 Białystok, Poland.
Insights
Chemerin levels in coronary artery disease (CAD) patients correlate with inflammation and insulin resistance. Its link to fat mass varies with glucose metabolism, suggesting different regulation mechanisms.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Chemerin, an adipokine and chemoattractant, is elevated in coronary artery disease (CAD).
- Understanding chemerin's associations with metabolic and body composition markers is crucial in CAD patients.
Purpose of the Study:
- To investigate the associations between serum chemerin levels and biochemical measurements.
- To explore the relationship between chemerin and body composition in patients with stable CAD.
Main Methods:
- Study included 163 patients with stable CAD post-percutaneous coronary intervention (PCI).
- Serum chemerin, insulin, and c-peptide levels were measured.
- Body composition was assessed using DEXA; biochemical markers were analyzed.
Main Results:
- Chemerin positively correlated with white blood cell count, neutrophil-to-lymphocyte ratio, hsCRP, lipid profiles, triglycerides, platelets, fasting insulin, and c-peptide.
- No significant difference in chemerin levels was found between diabetic and non-diabetic patients.
- Chemerin correlated with total fat mass only in patients with normal glucose metabolism.
Conclusions:
- Serum chemerin levels in CAD patients are linked to inflammation, insulin resistance, and dyslipidemia.
- The association between chemerin and fat mass is contingent on glucose metabolism status.
- Chemerin secretion regulation may differ based on diabetes or prediabetes presence.
Background:
Chemerin is an adipokine and a chemoattractant for leukocytes. Increased chemerin levels were observed in patients with coronary artery disease (CAD). We investigated associations between chemerin and biochemical measurements or body composition in CAD patients.
Methods:
In the study, we included patients with stable CAD who had undergone percutaneous coronary intervention (PCI) in the past. All patients had routine blood tests, and their insulin and chemerin serum levels were routinely measured. Body composition was assessed with the DEXA method.
Results:
The study group comprised 163 patients (mean age 59.8 ± years, 26% of females, n = 43). There was no significant difference in serum chemerin concentrations between patients with diabetes and the remaining ones: 306.8 ± 121 vs. 274.15 ± 109 pg/mL, p = 0.1. Chemerin correlated positively with the white blood cell (WBC) count, the neutrophil to lymphocyte ratio, hsCRP, all fractions of cholesterol, triglycerides, platelet count, fasting insulin, and c-peptide. Chemerin levels were also correlated with total fat mass but only in a subgroup with normal glucose metabolism.
Conclusion:
In patients with CAD, serum chemerin levels are correlated with inflammation markers, insulin resistance, and an unfavorable lipid profile. Correlation with fat mass is dependent on glucose metabolism status. Depending on the presence of diabetes/prediabetes, the mechanisms regulating chemerin secretion may be different.
More Related Videos
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
07:49Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction